Evidence map›Paper›PMID 31412022›Full record

ArticlePLoS neglected tropical diseases2019

Ecological niche modelling for predicting the risk of cutaneous leishmaniasis in the Neotropical moist forest biome.

Agathe Chavy, Alessandra Ferreira Dales Nava, Sergio Luiz Bessa Luz, Juan David Ramírez, Giovanny Herrera, Thiago Vasconcelos Dos Santos, Marine Ginouves, Magalie Demar, Ghislaine Prévot, Jean-François Guégan and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Analysis of the Current Risk ofTransboundary and emerging diseases · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Analysis of the current risk ofFrontiers in veterinary science · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Agathe ChavyLaboratoire des Interactions Virus-Hôtes, Institut Pasteur de la Guyane, Cayenne, French Guiana.
Alessandra Ferreira Dales NavaLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, EDTA Instituto Lêonidas e Maria Deane, FIOCRUZ, Amazonas, Brazil.
Sergio Luiz Bessa LuzLaboratório de Ecologia de Doenças Transmissíveis na Amazônia, EDTA Instituto Lêonidas e Maria Deane, FIOCRUZ, Amazonas, Brazil.
Juan David RamírezGrupo de Investigaciones Microbiológicas-UR (GIMUR), Programa de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogotá, Colombia.ORCID 0000-0002-1344-9312
Giovanny HerreraGrupo de Investigaciones Microbiológicas-UR (GIMUR), Programa de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogotá, Colombia.
Thiago Vasconcelos Dos SantosParasitology Unit, Instituto Evandro Chagas (Secretaria de Vigilância em Saúde, Ministério da Saúde), Ananindeua, Brazil.
Marine GinouvesLaboratoire des Ecosystèmes Amazoniens et Pathologie Tropicale, EA3593, Medicine Department, Université de Guyane, Cayenne, French Guiana.
Magalie DemarLaboratoire Associé du CNR Leishmaniose, Laboratoire Hospitalo-Universitaire de Parasitologie-Mycologie, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.
Ghislaine PrévotLaboratoire des Ecosystèmes Amazoniens et Pathologie Tropicale, EA3593, Medicine Department, Université de Guyane, Cayenne, French Guiana.
Jean-François GuéganUnité Mixte de Recherche MIVEGEC, Université de Montpellier, IRD, CNRS, Montpellier, France.
Benoît de ThoisyLaboratoire des Interactions Virus-Hôtes, Institut Pasteur de la Guyane, Cayenne, French Guiana.ORCID 0000-0002-8420-5112
University of French Guiana · GFFundação Oswaldo Cruz · BRUniversidad del Rosario · COCentre Hospitalier Andrée Rosemon · GFCentre National de la Recherche Scientifique · FRMinistério da Saúde · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A major challenge of eco-epidemiology is to determine which factors promote the transmission of infectious diseases and to establish risk maps that can be used by public health authorities. The geographic predictions resulting from ecological niche modelling have been widely used for modelling the future dispersion of vectors based on the occurrence records and the potential prevalence of the disease. The establishment of risk maps for disease systems with complex cycles such as cutaneous leishmaniasis (CL) can be very challenging due to the many inference networks between large sets of host and vector species, with considerable heterogeneity in disease patterns in space and time. One novelty in the present study is the use of human CL cases to predict the risk of leishmaniasis occurrence in response to anthropogenic, climatic and environmental factors at two different scales, in the Neotropical moist forest biome (Amazonian basin and surrounding forest ecosystems) and in the surrounding region of French Guiana. With a consistent data set never used before and a conceptual and methodological framework for interpreting data cases, we obtained risk maps with high statistical support. The predominantly identified human CL risk areas are those where the human impact on the environment is significant, associated with less contributory climatic and ecological factors. For both models this study highlights the importance of considering the anthropogenic drivers for disease risk assessment in human, although CL is mainly linked to the sylvatic and peri-urban cycle in Meso and South America.

Indexed as

EcologyEcosystemForestsFrench GuianaHumansLeishmaniasis, CutaneousPrevalenceSeasonsSouth America

Identifiers

PMID31412022
PMCPMC6693739
OpenAlexW2967778218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.